Is primary trabeculectomy cost-effective for patients with advanced primary open angle glaucoma? Results from the Treatment of Advanced Glaucoma Study economic model
Open Access
- 9 February 2024
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 108 (9) , 1210-1215
Abstract
Background/aims: Advanced primary open angle glaucoma (POAG) is a lifelong condition. The aim of this study is to compare medical treatment against trabeculectomy for patients presenting with advanced POAG using an economic evaluation decision model.Methods: A Markov model was used to compare the two treatments, medical treatment versus trabeculectomy for the management of advanced POAG, in terms of costs and quality-adjusted life-years (QALYs). The uncertainty surrounding the model findings was assessed using probabilistic sensitivity analysis and deterministic analysis. Data for the model came from Treatment of Advanced Glaucoma Study supplemented with data from the literature. The main outcomes of the model presented in terms of Incremental costs and QALYs based on responses to the EQ-5D-5L, Health Utilities Index-3 and a Glaucoma Utility Index.Results: In the base-case analysis (lifetime horizon and EQ-5D-5L measure), participants receiving trabeculectomy had on average, an additional cost of £2687, an additional 0.28 QALYs and an incremental cost per QALY of £9679 compared with medical treatment. There was a 73% likelihood of trabeculectomy being considered cost-effective when society was willing to pay £20 000 for a QALY. Over shorter time horizons, the incremental cost per QALY gained from trabeculectomy compared with medical treatment was higher (47 663) for a 2-year time horizon. Our results are robust to changes in the key assumptions and input parameters values.Conclusion: In patients presenting with advanced POAG, trabeculectomy has a higher probability of being cost-effective over a patient’s lifetime compared with medical treatment.Keywords
Funding Information
- Health Technology Assessment Programme (12/35/38)
This publication has 30 references indexed in Scilit:
- Comparative Cost-effectiveness of Trabeculectomy versus MicroShunt in the US Medicare SystemOphthalmology, 2022
- The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment StudyOphthalmology, 2020
- Systematic Review of Economic Evaluations in Primary Open-Angle Glaucoma: Decision Analytic Modeling InsightsPharmacoEconomics - Open, 2019
- Comparative Effectiveness of First-Line Medications for Primary Open-Angle GlaucomaOphthalmology, 2016
- Global Prevalence of Vision Impairment and BlindnessOphthalmology, 2013
- Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value SetsValue in Health, 2012
- Cost-effectiveness of Medications Compared With Laser Trabeculoplasty in Patients With Newly Diagnosed Open-Angle GlaucomaArchives of Ophthalmology (1950), 2012
- Glaucoma and Quality of LifeOphthalmology, 2008
- Severity of Visual Field Loss and Health-related Quality of LifeAmerican Journal of Ophthalmology, 2007
- The Collaborative Initial Glaucoma Treatment Study Interim quality of life findings after initial medical or surgical treatment of glaucomaOphthalmology, 2001